These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 6612135)

  • 21. Speech production in Parkinson's disease: II. Acoustic and electropalatographic investigation of sentence, word and segment durations.
    McAuliffe MJ; Ward EC; Murdoch BE
    Clin Linguist Phon; 2006; 20(1):19-33. PubMed ID: 16393796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parametric quantitative acoustic analysis of conversation produced by speakers with dysarthria and healthy speakers.
    Rosen KM; Kent RD; Delaney AL; Duffy JR
    J Speech Lang Hear Res; 2006 Apr; 49(2):395-411. PubMed ID: 16671852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment.
    D'Alatri L; Paludetti G; Contarino MF; Galla S; Marchese MR; Bentivoglio AR
    J Voice; 2008 May; 22(3):365-72. PubMed ID: 17368837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different lip asymmetry in adults who stutter: electromyographic evidence during speech and non-speech.
    Choo AL; Robb MP; Dalrymple-Alford JC; Huckabee ML; O'Beirne GA
    Folia Phoniatr Logop; 2010; 62(3):143-7. PubMed ID: 20424470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease.
    Pinto S; Gentil M; Fraix V; Benabid AL; Pollak P
    J Neurol; 2003 Feb; 250(2):179-87. PubMed ID: 12574948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences between Subjective and Objective Assessment of Speech Deficiency in Parkinson Disease.
    Pawlukowska W; Szylińska A; Kotlęga D; Rotter I; Nowacki P
    J Voice; 2018 Nov; 32(6):715-722. PubMed ID: 29122413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysarthrias of movement disorders.
    Hartman DE; Abbs JH
    Adv Neurol; 1988; 49():289-306. PubMed ID: 3278545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prominence marking in parkinsonian speech and its correlation with motor performance and cognitive abilities.
    Thies T; Mücke D; Lowit A; Kalbe E; Steffen J; Barbe MT
    Neuropsychologia; 2020 Feb; 137():107306. PubMed ID: 31857118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orofacial myofunctional therapy in dysarthria: a study on speech intelligibility.
    Ray J
    Int J Orofacial Myology; 2002 Nov; 28():39-48. PubMed ID: 12572259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of upper and lower lip muscle activity between stutterers and fluent speakers.
    de Felício CM; Freitas RL; Vitti M; Regalo SC
    Int J Pediatr Otorhinolaryngol; 2007 Aug; 71(8):1187-92. PubMed ID: 17512612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dysarthria across Parkinson's disease progression. Natural history of its components: dysphonia, dysprosody and dysarthria].
    Pinto S; Ghio A; Teston B; Viallet F
    Rev Neurol (Paris); 2010 Oct; 166(10):800-10. PubMed ID: 20800250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expiratory muscle strength training: speech production outcomes in patients with multiple sclerosis.
    Chiara T; Martin D; Sapienza C
    Neurorehabil Neural Repair; 2007; 21(3):239-49. PubMed ID: 17351085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender-related patterns of dysprosody in Parkinson disease and correlation between speech variables and motor symptoms.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Jan; 25(1):76-82. PubMed ID: 20381998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rate and loudness manipulations in dysarthria: acoustic and perceptual findings.
    Tjaden K; Wilding GE
    J Speech Lang Hear Res; 2004 Aug; 47(4):766-83. PubMed ID: 15324285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of Parkinson's disease on vocal-prosodic communication from the perspective of listeners.
    Pell MD; Cheang HS; Leonard CL
    Brain Lang; 2006 May; 97(2):123-34. PubMed ID: 16226803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breath-group intelligibility in dysarthria: characteristics and underlying correlates.
    Yunusova Y; Weismer G; Kent RD; Rusche NM
    J Speech Lang Hear Res; 2005 Dec; 48(6):1294-310. PubMed ID: 16478372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acoustic analysis of voice in dysarthria following stroke.
    Wang YT; Kent RD; Kent JF; Duffy JR; Thomas JE
    Clin Linguist Phon; 2009 May; 23(5):335-47. PubMed ID: 19399666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bradykinetic utterances and monopitch speech in patients with Parkinson's disease].
    Kawada N; Miyazaki M; Matsuyama M; Murai K; Nakatani K
    Rinsho Shinkeigaku; 2004 Oct; 44(10):703-6. PubMed ID: 15568489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EMG activity of orbicularis oris superior, orbicularis oris inferior, and masseter muscles of articulatory disordered children.
    Rastatter M; De Jarnette G
    Percept Mot Skills; 1984 Feb; 58(1):191-6. PubMed ID: 6718182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of subthalamic nucleus stimulation on parkinsonian dysarthria and speech intelligibility.
    Rousseaux M; Krystkowiak P; Kozlowski O; Ozsancak C; Blond S; Destée A
    J Neurol; 2004 Mar; 251(3):327-34. PubMed ID: 15015014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.